Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1057)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (19)
  8. Conference Paper (15)
  9. Correspondence (12)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2698)
  2. Department of Medicine (2698)
  3. Hematologic Malignancies, Division of (2698)
  4. Population Sciences Research Program (744)
  5. Survivorship Research (655)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (782)
  2. Steven Horwitz (666)
  3. Maria Palomba (445)
  4. Ariela Noy (371)
  5. David Straus (360)
  6. Alison Moskowitz (358)

More People

Years
  1. 2025 (45)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (876)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (83)
  5. British Journal of Haematology (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (941)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2698)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical research methods
    Book Section

    Batlevi, C. L.; Spriggs, D. R.; Motzer, R. J.; Morikawa, A.; Gucalp, A.; Vickers, A. J.; Riely, G. J.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • General oncology
    Book Section

    Kumar, A.; Blinder, V.; Shah, P. D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Improvements in treatments for Hodgkin lymphoma over a 50-year period lead to fewer second malignancies
    Meeting Abstract

    Dabaja, B.; Shihadeh, F.; Rodriguez, M.; Etzel, C.; Liang, F.; Shirvani, S. M.; Ballas, L. K.; Allen, P.; Fanale, M.; Wogan, C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Non-Hodgkin's lymphomas, version 4.2014
    Journal Article

    Zelenetz, A. D.; Gordon, L. I.; Wierda, W. G.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Byrd, J. C.; Czuczman, M. S.; Fayad, L. E.; more...
    Journal of the National Comprehensive Cancer Network (2014)

    Fulltext@MSK | Save
  • Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: A multicenter retrospective analysis
    Journal Article

    Petrich, A. M.; Gandhi, M.; Jovanovic, B.; Castillo, J. J.; Rajguru, S.; Yang, D. T.; Shah, K. A.; Whyman, J. D.; Lansigan, F.; Hernandez-Ilizaliturri, F. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral t-cell lymphomas: Results of a phase I study
    Journal Article

    Fanale, M. A.; Horwitz, S. M.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R. W.; Davies, A.; Illidge, T.; Huebner, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: A non-randomised, phase 1b study
    Journal Article

    Younes, A.; Thieblemont, C.; Morschhauser, F.; Flinn, I.; Friedberg, J. W.; Amorim, S.; Hivert, B.; Westin, J.; Vermeulen, J.; Bandyopadhyay, N.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project
    Journal Article

    Carson, K. R.; Newsome, S. D.; Kim, E. J.; Wagner-Johnston, N. D.; Von Geldern, G.; Moskowitz, C. H.; Moskowitz, A. J.; Rook, A. H.; Jalan, P.; Loren, A. W.; more...
    Cancer (2014)

    Fulltext@MSK | Save
  • Diffuse large B cell lymphoma: Using pathologic and molecular biomarkers to define subgroups for novel therapy
    Journal Article

    Carbone, A.; Gloghini, A.; Kwong, Y. L.; Younes, A.
    Annals of Hematology (2014)

    Fulltext@MSK | Save
  • Evolving treatment paradigms for primary mediastinal diffuse large B-cell lymphoma
    Journal Article

    Hamlin, P. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save